Evidence map›Paper›PMID 38386953›Full record

Observational studyJCO global oncology2024

Evaluation of Pathway to Diagnosis of Pediatric Brain Tumors in Tamil Nadu, India.

Prerna Kartik, Jo-Fen Liu, Rishan Thimma Sudarsan, Aarthi Srinivasan, Dhaarani Jayaraman, Ponni Sivaprakasam, Rikki John, Ramya Uppuluri, Julius Xavier Scott, Rakesh Jalali and 1 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in JCO global oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Surgical treatment of pediatric low-grade glioma in developing countries.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Prerna KartikSchool of Medicine, University of Nottingham, Nottingham, United Kingdom.ORCID 0000-0003-1855-8881
Jo-Fen LiuLifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Rishan Thimma SudarsanApollo Proton Cancer Centre, Chennai, India.
Aarthi SrinivasanKanchi Kamakoti Childs Trust Hospital, Chennai, India.ORCID 0000-0001-9177-1019
Dhaarani JayaramanSri Ramachandra Institute for Higher Education and Research, Chennai, India.
Ponni SivaprakasamGleneagles Global Hospital, Chennai, India.
Rikki JohnChristian Medical College, Vellore, India.ORCID 0000-0001-5547-5829
Ramya UppuluriApollo Proton Cancer Centre, Chennai, India.ORCID 0000-0001-5771-8214
Julius Xavier ScottSri Ramachandra Institute for Higher Education and Research, Chennai, India.
Rakesh JalaliKanchi Kamakoti Childs Trust Hospital, Chennai, India.ORCID 0000-0002-0318-5536
Madhumita DandapaniChildren's Brain Tumour Research Centre, University of Nottingham, Nottingham, United Kingdom.ORCID 0000-0001-8444-6007
University of Nottingham · GBApollo Proton Cancer Centre · INKanchi Kamakoti CHILDS Trust Hospital · INSri Ramachandra Institute of Higher Education and Research · INChristian Medical College, Vellore · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDelayed diagnosis and poor awareness are significant barriers to the early intervention of pediatric brain tumors. This multicenter observational study aimed to evaluate the baseline routes and time to diagnosis for pediatric brain tumors in Tamil Nadu (TN), with the goal of promoting early diagnosis and timely referrals in the future.

methodsA standard proforma was used to retrospectively collect information on demographics, diagnosis, referral pathways, and symptoms of incident pediatric brain tumor cases between January 2018 and October 2020 across eight tertiary hospitals in TN. Dates of symptom onset, first presentation of health care, and diagnosis were used to calculate total diagnostic interval (TDI), patient interval (PI), and diagnostic interval (DI).

resultsA total of 144 cases (mean age, 6.64 years; range, 0-15.1 years) were included in the analysis. Among those, 94% (135/144) were from city/district areas, 40% (55/144) were self-referred, and 90% (129/144) had one to three health care professional visits before diagnosis. Median TDI, PI, and DI were 3.5 (IQR, 1-9.3), 0.6 (IQR, 0.1-4.6), and 0.6 (IQR, 0-3.3) weeks, respectively. Low-grade gliomas had the longest median TDI (6.6 weeks), followed by medulloblastomas (4.6 weeks) and high-grade gliomas (3.3 weeks). Average number of symptoms recorded was 1.7 at symptom onset and 1.9 at diagnosis.

conclusionAlthough there are some similarities with data from the United Kingdom, many low-grade and optic pathway tumors were unaccounted for in our study. DIs were relatively short, which suggests that infrastructure may not be a problem in this cohort. Increased training and establishment of proper cancer registries, combined with proper referral pathways, could enhance early diagnosis for these children.

Indexed as

Brain NeoplasmsGliomaAdolescentChildChild, PreschoolHumansIndiaInfantInfant, NewbornReferral and ConsultationRetrospective Studies

Identifiers

PMID38386953
PMCPMC10898677
OpenAlexW4392028822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.